A Double-Blind, Randomized, Placebo-Controlled Study Evaluating the Nutritional Supplement Lumenato and Its Impact on Skin Parameters in Healthy Female Subjects

Inclusion criteria: * Resides in the United States * Generally healthy women between the ages of 35-55 * Fitzpatrick skin types 2 or 3 * Identifies as one of the following: White, Hispanic/Latino, or both White and Hispanic/Latino * Type 2 on the Glogau Skin Classification scale * Has expressed interest in improving skin health and appearance * Willing and able to follow the procedures of the study * Willing to refrain from changing their diet or lifestyle significantly for the duration of the study * Able to understand the study requirements and activities in English, and provide informed consent * Access to reliable internet service and smartphone in order to utilize the ClaimIt software/app needed to remotely participate in the study Exclusion Criteria: * Participants with Fitzpatrick skin types of 1, 4, 5 or 6 * Known allergies or sensitivity to tomato, latex and/or potato * Current use or use within 1 month of study enrollment of hormonal therapies (including hormonal contraceptives) * Current, regular use or regular use within 1 month of study enrollment of oral steroids; regular use defined as \>10 consecutive days * Chronic or relapsing inflammatory and/or allergic skin conditions such as atopic dermatitis, rosacea, psoriasis and alike including telangiectasias ("spider veins") * Pregnant, lactating or breastfeeding women (within the last 6 months) or those planning to become pregnant during the study period * Less than 2 years since diagnosis or treatment of skin …